ArticleNeuropsychiatric disease and treatment2017

Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase III, noninferiority study.

Adam J Savitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.